换一批
换一批摘要肺癌脑转移的发生影响患者预后,抗血管生成治疗成为继手术、全脑放疗、立体定位放疗和化疗之后肺癌脑转移患者新的治疗选择.贝伐珠单抗作为一种抗血管生成药物,具有较好的控制瘤周水肿的作用.研究表明,贝伐珠单抗联合化、放疗治疗非小细胞肺癌脑转移具有较好的疗效及安全性.
更多相关知识
abstractsThe occurrence of brain metastases in lung cancer affects the prognosis of patients.Following surgery,whole brain radiotherapy,stereotactic radiotherapy and chemotherapy,anti-angiogenesis therapy has become a new treatment option for lung cancer patients with brain metastases.As an anti-angiogenic drug,bevacizumab has a better effect of controlling peritumoral edema.Studies have shown that bevacizumab combined with chemotherapy,radiotherapy to treat non-small cell lung cancer with brain metastasis has a good efficacy and safety.
More相关知识
栏目名称
综述
DOI
10.3760/cma.j.issn.1673-422X.2017.11.015
发布时间
2018-01-25
- 浏览300
- 被引6
- 下载278
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
